Abstract
Here we report a 58-year-old man with chronic myelogenous leukemia in the chronic phase, who developed acute respiratory failure following administration of high dose natural interferon delta (6,300 x 10(4) units/week). Radiological and histological findings were consistent with acute interstitial pneumonia (AIP). Although the pathogenesis remains unclear, it is important to watch for the possible development of AIP when employing interferon delta therapy, especially at high doses.
MeSH terms
-
Acute Disease
-
Antineoplastic Agents / administration & dosage
-
Combined Modality Therapy
-
Etoposide / administration & dosage
-
Humans
-
Interferon Type I / administration & dosage
-
Interferon Type I / adverse effects*
-
Leukemia, Myeloid, Chronic-Phase / complications
-
Leukemia, Myeloid, Chronic-Phase / drug therapy
-
Leukemia, Myeloid, Chronic-Phase / therapy*
-
Lung Diseases, Interstitial / diagnosis
-
Lung Diseases, Interstitial / etiology*
-
Lung Diseases, Interstitial / pathology
-
Male
-
Middle Aged
-
Nitrosourea Compounds / administration & dosage
-
Pulmonary Alveoli / pathology
Substances
-
Antineoplastic Agents
-
Interferon Type I
-
Nitrosourea Compounds
-
interferon, delta
-
Etoposide
-
ranimustine